451 related articles for article (PubMed ID: 11836356)
1. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.
Balemans W; Patel N; Ebeling M; Van Hul E; Wuyts W; Lacza C; Dioszegi M; Dikkers FG; Hildering P; Willems PJ; Verheij JB; Lindpaintner K; Vickery B; Foernzler D; Van Hul W
J Med Genet; 2002 Feb; 39(2):91-7. PubMed ID: 11836356
[TBL] [Abstract][Full Text] [Related]
2. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
Balemans W; Ebeling M; Patel N; Van Hul E; Olson P; Dioszegi M; Lacza C; Wuyts W; Van Den Ende J; Willems P; Paes-Alves AF; Hill S; Bueno M; Ramos FJ; Tacconi P; Dikkers FG; Stratakis C; Lindpaintner K; Vickery B; Foernzler D; Van Hul W
Hum Mol Genet; 2001 Mar; 10(5):537-43. PubMed ID: 11181578
[TBL] [Abstract][Full Text] [Related]
3. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.
Staehling-Hampton K; Proll S; Paeper BW; Zhao L; Charmley P; Brown A; Gardner JC; Galas D; Schatzman RC; Beighton P; Papapoulos S; Hamersma H; Brunkow ME
Am J Med Genet; 2002 Jun; 110(2):144-52. PubMed ID: 12116252
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
Sebastian A; Loots GG
Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
[TBL] [Abstract][Full Text] [Related]
5. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.
Balemans W; Cleiren E; Siebers U; Horst J; Van Hul W
Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites.
Uitterlinden AG; Arp PP; Paeper BW; Charmley P; Proll S; Rivadeneira F; Fang Y; van Meurs JB; Britschgi TB; Latham JA; Schatzman RC; Pols HA; Brunkow ME
Am J Hum Genet; 2004 Dec; 75(6):1032-45. PubMed ID: 15514891
[TBL] [Abstract][Full Text] [Related]
7. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.
Balemans W; Van Den Ende J; Freire Paes-Alves A; Dikkers FG; Willems PJ; Vanhoenacker F; de Almeida-Melo N; Alves CF; Stratakis CA; Hill SC; Van Hul W
Am J Hum Genet; 1999 Jun; 64(6):1661-9. PubMed ID: 10330353
[TBL] [Abstract][Full Text] [Related]
8. Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.
Kim SJ; Bieganski T; Sohn YB; Kozlowski K; Semënov M; Okamoto N; Kim CH; Ko AR; Ahn GH; Choi YL; Park SW; Ki CS; Kim OH; Nishimura G; Unger S; Superti-Furga A; Jin DK
Hum Genet; 2011 May; 129(5):497-502. PubMed ID: 21221996
[TBL] [Abstract][Full Text] [Related]
9. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
10. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.
Loots GG; Kneissel M; Keller H; Baptist M; Chang J; Collette NM; Ovcharenko D; Plajzer-Frick I; Rubin EM
Genome Res; 2005 Jul; 15(7):928-35. PubMed ID: 15965026
[TBL] [Abstract][Full Text] [Related]
11. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
12. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
13. Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.
Belkhribchia MR; Collet C; Laplanche JL; Hassani R
Eur J Med Genet; 2014 Mar; 57(4):133-7. PubMed ID: 24594238
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins and their antagonists: the sclerostin paradigm.
van Bezooijen RL; Papapoulos SE; Löwik CW
J Endocrinol Invest; 2005; 28(8 Suppl):15-7. PubMed ID: 16323824
[TBL] [Abstract][Full Text] [Related]
15. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.
Brunkow ME; Gardner JC; Van Ness J; Paeper BW; Kovacevich BR; Proll S; Skonier JE; Zhao L; Sabo PJ; Fu Y; Alisch RS; Gillett L; Colbert T; Tacconi P; Galas D; Hamersma H; Beighton P; Mulligan J
Am J Hum Genet; 2001 Mar; 68(3):577-89. PubMed ID: 11179006
[TBL] [Abstract][Full Text] [Related]
16. A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.
Kim CA; Honjo R; Bertola D; Albano L; Oliveira L; Jales S; Siqueira J; Castilho A; Balemans W; Piters E; Jennes K; Van Hul W
Genet Test; 2008 Dec; 12(4):475-9. PubMed ID: 19072561
[TBL] [Abstract][Full Text] [Related]
17. Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21.
Van Hul W; Balemans W; Van Hul E; Dikkers FG; Obee H; Stokroos RJ; Hildering P; Vanhoenacker F; Van Camp G; Willems PJ
Am J Hum Genet; 1998 Feb; 62(2):391-9. PubMed ID: 9463328
[TBL] [Abstract][Full Text] [Related]
18. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family.
He WT; Chen C; Pan C; Zhang MX; Yu XF; Wang DW; Hu SH
Clin Genet; 2016 Feb; 89(2):205-9. PubMed ID: 26283468
[TBL] [Abstract][Full Text] [Related]
19. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.
Whyte MP; Deepak Amalnath S; McAlister WH; Pedapati R; Muthupillai V; Duan S; Huskey M; Bijanki VN; Mumm S
Bone; 2018 Nov; 116():321-332. PubMed ID: 30077757
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
